Human brain monoamine oxidase: one molecular entity-multiple binding sites?
Monoamine oxidase (MAO) of human brain cortex was partially characterized by using different substrates and inhibitors. Two Km values were calculated for each of the three substrates tested, i.e., phenethylamine (PEA) benzylamine (BA) and 5-hydroxtryptamine (5-HT). Clorgyline and 5-HT, both known as MAO-A occupants, were able to abolish the second (high) Km deamination of PEA. 5-HT, while non-competitively inhibiting the deamination of low BA concentrations, competitively inhibited the deamination of high concentrations of this type B substrate. The kinetics of 5-HT deamination showed positive cooperation which indicates the involvement of subunits in the enzyme structure. The ability of some phospholipids to change the enzyme behaviour was considered as indication that these molecules might play a role in determining the ratio between the so-called A and B types of MAO, and in the regulation of the enzyme's activity.
D001665:Binding Sites; D001921:Brain / Q000201:enzymology*; D003641:Deamination; D006801:Humans; D007700:Kinetics; D008995:Monoamine Oxidase / Q000378:metabolism*; D010627:Phenethylamines / Q000378:metabolism; D010713:Phosphatidylcholines / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism
D010627:Phenethylamines; D010713:Phosphatidylcholines; C029261:phenethylamine; D012701:Serotonin; D008995:Monoamine Oxidase